Pieris Pharmaceuticals Inc (PIRS)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 95.49M | 82.26M | 87.54M | 59.38M | 38.68M | 29.5M | 25.05M | 20.52M |
流動資産合計 | 73.42M | 60.51M | 66.47M | 59.09M | 38.68M | 29.5M | 25.05M | 20.52M |
現金および同等物 | 38.64M | 39.74M | 44.94M | 32.89M | 17.4M | 19.08M | 19.73M | 19.36M |
非流動資産合計 | 39.06M | 38.46M | 37.24M | 287k | 0 | 0 | 0 | 0 |
負債合計 | 67.56M | 66.8M | 47.05M | 28.87M | 11.92M | 7.53M | 6.35M | 4.25M |
流動負債合計 | 36.58M | 42.88M | 34.37M | 28.87M | 11.92M | 7.53M | 6.35M | 4.25M |
非流動負債合計 | 30.98M | 23.93M | 12.68M | 0 | 0 | 0 | 0 | 0 |
普通株 | 74k | 74k | 99k | 99k | 98k | 1,000 | 1,000 | 1,000 |
留保所得 | -290.42M | -303.6M | -299.63M | -310.38M | -314.96M | -319.86M | -323.45M | -326.33M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 35.06M | 103.88M | 141.34M | 141.1M | 105.01M | 153.56M | 95.49M | 38.68M |
流動資産合計 | 32.67M | 89.79M | 135.38M | 115.01M | 75.72M | 127.63M | 73.42M | 38.68M |
現金および同等物 | 29.36M | 37.88M | 74.87M | 62.26M | 70.44M | 117.76M | 38.64M | 17.4M |
非流動資産合計 | 25.23M | 11.52M | 39.94M | 51.35M | 31.03M | 50.76M | 27.93M | 26.76M |
負債合計 | 9.84M | 92.35M | 101.41M | 89.75M | 73.98M | 102.81M | 67.56M | 11.92M |
流動負債合計 | 8.38M | 45.78M | 48.08M | 27M | 22.15M | 50.56M | 36.58M | 11.92M |
非流動負債合計 | 1.46M | 46.58M | 53.33M | 62.74M | 51.84M | 52.24M | 30.98M | 0 |
総資本 | 25.23M | 11.52M | 39.94M | 51.35M | 31.03M | 50.76M | 27.93M | 26.76M |
普通株 | 43k | 45k | 54k | 55k | 56k | 72k | 74k | 98k |
留保所得 | -102.67M | -120.31M | -147.07M | -174.18M | -211.41M | -257.14M | -290.42M | -314.96M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約